Zynex, Inc. Announces Filing of Patent for Sepsis Monitor
January 14, 2021 at 09:15 am
Share
Zynex, Inc. reported it has filed for a provisional patent for a noninvasive sepsis monitor. Sepsis is a life-threatening medical condition characterized by the body-wide inflammatory response or reaction that presents in response to infection. The inflammatory response triggered by the immune reaction can cause body-wide tissue damage, even to areas not local to the original infection. Bacterial infections are the most common cause of sepsis, but sepsis can also be caused by fungal, parasitic, or viral infections. As an ineffectively treated infection progresses, toxins from the infection may circulate in the blood stream, causing damage to other organs (such as the brain, heart, lungs, kidneys, liver, etc.) and tissues. As the damage progresses, septic shock and a fatal decline in blood pressure may occur; patients with additional medical conditions and risk factors have increased likelihood of death.
Sepsis treatment spans multiple days to weeks, often in an intensive care environment and is detected through blood cultures, blood-gas analysis, kidney and other organ functional tests, platelet and white blood cell counts, additional imaging, urine testing, cerebrospinal fluid tests, etc.
The signs and symptoms of sepsis often may be subtle. The low survival rate of patients with severe sepsis indicates that current sepsis identification strategies, tools, and methods may be lacking.
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Companyâs devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâs products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.